Tanvex BioPharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Henry Chen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 8.9yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -NT$2b |
| Sep 30 2023 | n/a | n/a | -NT$2b |
| Jun 30 2023 | n/a | n/a | -NT$2b |
| Mar 31 2023 | n/a | n/a | -NT$2b |
| Dec 31 2022 | n/a | n/a | -NT$2b |
| Sep 30 2022 | n/a | n/a | -NT$2b |
| Jun 30 2022 | n/a | n/a | -NT$2b |
| Mar 31 2022 | n/a | n/a | -NT$1b |
| Dec 31 2021 | NT$5k | n/a | -NT$2b |
| Sep 30 2021 | n/a | n/a | -NT$2b |
| Jun 30 2021 | n/a | n/a | -NT$2b |
| Mar 31 2021 | n/a | n/a | -NT$2b |
| Dec 31 2020 | NT$150k | NT$150k | -NT$2b |
| Sep 30 2020 | n/a | n/a | -NT$2b |
| Jun 30 2020 | n/a | n/a | -NT$2b |
| Mar 31 2020 | n/a | n/a | -NT$2b |
| Dec 31 2019 | n/a | n/a | -NT$2b |
| Sep 30 2019 | n/a | n/a | -NT$2b |
| Jun 30 2019 | n/a | n/a | -NT$2b |
| Mar 31 2019 | n/a | n/a | -NT$2b |
| Dec 31 2018 | NT$15k | n/a | -NT$2b |
| Sep 30 2018 | n/a | n/a | -NT$2b |
| Jun 30 2018 | n/a | n/a | -NT$2b |
| Mar 31 2018 | n/a | n/a | -NT$1b |
| Dec 31 2017 | NT$10k | n/a | -NT$1b |
Compensation vs Market: Insufficient data to establish whether Henry's total compensation is reasonable compared to companies of similar size in the TW market.
Compensation vs Earnings: Henry's compensation has been consistent with company performance over the past year.
CEO
Henry Chen (52 yo)
less than a year
Tenure
NT$5,000
Compensation
Dr. Lin-Cheng Chen, also known as Henry, serves as Chairman of Tanvex BioPharma, Inc. since December 29, 2023 and serves as Chief Executive Officer since February 6, 2024. He is the Founder and Managing Pa...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | less than a year | NT$5.00k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Director of Operation Management & Corporate Governance Officer | no data | no data | no data | |
| Accounting Officer | less than a year | no data | no data | |
| Chief Technology Officer | 9.3yrs | no data | no data | |
| Director of Sales & Marketing | no data | no data | no data | |
| Secretary | no data | no data | no data |
0.3yrs
Average Tenure
Experienced Management: 6541's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | less than a year | NT$5.00k | no data | |
| Honorary Chairman | 10.8yrs | NT$111.00k | 5.35% NT$ 420.9m | |
| Director | 8.9yrs | no data | 0.53% NT$ 41.5m | |
| Director | 10.5yrs | NT$25.00k | 0.010% NT$ 785.0k | |
| Director | 10.5yrs | NT$35.00k | no data | |
| Independent Director | 8.9yrs | NT$703.00k | no data | |
| Independent Director | 2.7yrs | NT$893.00k | no data | |
| Independent Director | 1.8yrs | NT$570.00k | no data |
8.9yrs
Average Tenure
71yo
Average Age
Experienced Board: 6541's board of directors are considered experienced (8.9 years average tenure).